ABIRAKAST ABIRATERONE ACETATE 250 MG TABLETS

Send Inquiry

Request To Call Back

ABIRAKAST ABIRATERONE ACETATE 250 MG TABLETS

Get a Price/Quote

MOQ : 1 Bottle

ABIRAKAST ABIRATERONE ACETATE 250 MG TABLETS Specification

Indication
Metastatic castration-resistant prostate cancer (mCRPC)

Pacakaging (Quantity Per Box)
120 tablets per bottle

Origin of Medicine
Imported

Salt Composition
Abiraterone Acetate 250 mg

Dosage Form
Oral tablet

Drug Type
Allopathic

Ingredients
Abiraterone Acetate

Physical Form
Tablet

Function
Anti-cancer medication

Recommended For
Prostate Cancer Patients

Dosage
As prescribed by the physician, typically 1000 mg (4 tablets) once daily

Dosage Guidelines
Should be taken on an empty stomach, at least one hour before or two hours after food

Suitable For
Adults

Quantity
120 tablets

Storage Instructions
Store below 30C, protect from light and moisture

Color
White to off-white

Strength
250 mg per tablet

Therapeutic Class
Antineoplastic agent

Warning & Precaution
For use under medical supervision only. Not to be used in women or children.

Side Effects
Hypertension, joint swelling or discomfort, hypokalemia, edema, hot flushes

Prescription Required
Yes

Brand Name
Abirakast

ATC Code
L02BX03

Administration Route
Oral

Shape
Oval-shaped film-coated tablets

Marketed By
Aprazer Healthcare Pvt. Ltd.

Shelf Life
24 months from date of manufacture

ABIRAKAST ABIRATERONE ACETATE 250 MG TABLETS Trade Information

Minimum Order Quantity
1 Bottle

Packaging Details
PACK OF 120 TABLETS

About ABIRAKAST ABIRATERONE ACETATE 250 MG TABLETS

PRODUCT DETAILS

BRAND NAME: ABIRAKAST

CONTENT: ABIRATERONE ACETATE

STRENGTH:250MG

PACKAGING: PACK OF 120 TABLETS

MANUFACTURED BY: APRAZER

Note : -ABIRAKASTIs A Prescription Drug And Should Be Used Under Proper Medical Guidance AndAdvice. Do Not Share The Medicine With Others, Since They May Be Suffering FromA Problem That Is Not Effectively Treated By This Drug................

Therapeutic Benefits

Abirakast offers clinical advantages in managing metastatic castration-resistant prostate cancer by inhibiting androgen biosynthesis. This mechanism helps slow the progression of the disease and is recommended for adult male patients under a physicians guidance. Patients prescribed Abirakast experience enhanced treatment outcomes through continuous medical supervision.

Dosage and Administration

Abirakast is administered orally, with a typical recommended dosage of 1000 mg (four 250 mg tablets) taken once daily. It is vital to take the tablets on an empty stomach, either one hour before or two hours after food, ensuring optimal absorption. Dosage should always be determined and adjusted by a healthcare professional.

Storage and Handling

Proper storage of Abirakast extends its efficacy and shelf life. The tablets must be kept below 30C, away from light and moisture, and in the original packaging. Following these instructions helps maintain product stability and therapeutic effectiveness throughout the recommended shelf life.

FAQs of ABIRAKAST ABIRATERONE ACETATE 250 MG TABLETS:

Q: How should Abirakast tablets be taken for maximum effectiveness?

A: Abirakast tablets should be taken orally as advised by your physician, typically 1000 mg (four tablets) once daily on an empty stomachat least one hour before or two hours after eatingfor optimal absorption.

Q: What is the primary indication for prescribing Abirakast?

A: Abirakast is indicated for the treatment of metastatic castration-resistant prostate cancer (mCRPC) in adult male patients. It should only be used under medical supervision.

Q: When is the best time to take Abirakast tablets?

A: The best time to take Abirakast is either one hour before a meal or two hours after eating to ensure the medicine is properly absorbed and effective.

Q: Where should Abirakast be stored to maintain its potency?

A: These tablets must be stored below 30C, protected from light and moisture, and kept in the original packaging to preserve their effectiveness until the expiration date.

Q: What are the possible side effects associated with Abirakast?

A: Common side effects include hypertension, joint swelling or discomfort, hypokalemia, edema, and hot flushes. Inform your physician of any symptoms to ensure proper management.

Q: Who is Abirakast recommended for and is a prescription required?

A: Abirakast is recommended for adult men with metastatic castration-resistant prostate cancer. It is a prescription-only medicine and must be used under the supervision of a qualified healthcare professional.

Q: What are the benefits of using Abirakast for prostate cancer patients?

A: Abirakast helps inhibit androgen production, slowing disease progression and improving response rates in patients with advanced prostate cancer, all under rigorous medical supervision for safety and efficacy.

Tell us about your requirement